Clinical and research tests for C0349535 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 43

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Hereditary Gastric Cancer Panel QDx Pathology Services, Inc. United States	4	6	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Gastric Cancer Panel Clariti Diagnostics Laboratories LLC United States	4	6	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Carcinoid tumors, intestinal, 114900, Autosomal dominant (Carcinoid tumor and carcinoid syndrome) (SDHD gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Carcinoid tumors, intestinal, 114900, Autosomal dominant (Carcinoid tumor and carcinoid syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	D Deletion/duplication analysis
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States	147	18	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for RenalNext® (+RNAinsight®) Ambry Genetics United States	57	7	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for PGLNext® (+RNAinsight®) Ambry Genetics United States	26	1	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States	95	71	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Pediatric Cancer Panel PreventionGenetics, part of Exact Sciences United States	78	64	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
RenalNext® Ambry Genetics United States	57	20	D Deletion/duplication analysis C Sequence analysis of the entire coding region
PGLNext® Ambry Genetics United States	26	14	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CustomNext-Cancer® Ambry Genetics United States	147	91	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CancerNext-Expanded® Ambry Genetics United States	122	71	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Renal Cancer Panel PreventionGenetics, part of Exact Sciences United States	33	25	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Paraganglioma-Pheochromocytoma (PGL/PCC) Syndrome Panel PreventionGenetics, part of Exact Sciences United States	13	13	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Paraganglioma-Pheochromocytoma Syndrome via the SDHD Gene PreventionGenetics, part of Exact Sciences United States	3	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
SDHD Institute of Human Genetics Medical University Innsbruck Austria	5	1	S Mutation scanning of the entire coding region C Sequence analysis of the entire coding region
Hereditary pediatric cancer panel. NGS panel of 71 genes. Genologica Medica Spain	158	71	C Sequence analysis of the entire coding region
Hereditary endocrine cancer panel. NGS panel of 22 genes. Genologica Medica Spain	68	22	C Sequence analysis of the entire coding region
Hereditary kidney cancer panel. NGS panel of 26 genes. Genologica Medica Spain	74	26	C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 43

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.